Powder for Suspension
Paclinab® is a microtubule inhibitor indicated for the treatment of paitients with Metastatic breast cancer, Locally advanced or metastatic non-small cell lung cancer, Metastatic adenocarcinoma of pancreas.
is recommended by guidelines such as NCCN and ESMO as first line regimens in metastatic pancreatic cancer in combination with gemcitabine and and in non-small cell lung cancer in combination with carboplatin.
